Signaling Pathways - MDM2 - MK2 - c-MET - Leukotriene and Related Receptors
清除全部
-
C5545 MK2 Inhibitor IVTarget: MK2Summary: 高选择性、非ATP竞争性MK2抑制剂 -
B5832 Altiratinib1 CitationTarget: FLT3|VEGFR|Trk Receptors|c-MET|Tie-2Summary: c-MET/TIE-2/VEGFR抑制剂 -
B6962 CMPD-1Target: Microtubules/Tubulins|MK2Summary: p38α介导的MK2a磷酸化的抑制剂 -
B5549 PF-3644022Target: MK2Summary: MK2抑制剂 -
B7023 MK-571Target: Leukotriene and Related ReceptorsSummary: leukotriene D4（LTD4)受体拮抗剂 -
B2068 Zafirlukast中文名: 扎鲁司特Target: Leukotriene and Related ReceptorsSummary: 口服白三烯受体拮抗剂 -
A8448 INCB28060中文名: 苯扎米特Target: c-METSummary: C-Met抑制剂 -
A5057 MGCD-265Target: VEGFR|c-METSummary: Met/Flt/Flk/Ron/Tie-2抑制剂 -
A2412 CP-724714Target: VEGFR|PDGFR|Bcr-Abl|Src|EGFR|c-MET|Insulin Receptors|IRG-1RSummary: 有效的HER2选择性抑制剂 -
A5096 PF-04217903Target: c-METSummary: C-Met的选择性和ATP竞争性抑制剂